skip to Main Content
Coloradans With MMJ Cards Score Bargains

It arrives in pre-rolled joints and by the ounce in plastic containers. It is turned into oil and gets smoked, or is used to saturate gummy bears and brownies. Teas contain it. Salves include it as an ingredient. Pills? It finds its way into capsules, tablets and softgels.

Nearly everything for sale at dispensaries in Colorado, Washington, Oregon and California contains cannabis in one form or another.

But prices for marijuana products vary wildly.  And one discrete channel among the many through which cannabis is sold in these states has the cheapest weed in any form – in some cases by a long shot.

Whether they are buying flower, edibles or concentrates, residents of Colorado with medical marijuana cards pay the least for grams of flower, and edibles and concentrates products according to cannabis market research firm BDS Analytics.

Prices for Colorado’s top 20 strains in the medical channel vary, but all are fairly low compared to prices in other channels and states.

Between January and September of this year, for example, people buying through Colorado’s medical channel paid on average $3.78 for a gram of marijuana. The most expensive place to buy weed? Pity those Californians paying more than twice as much for a gram of weed — $9.39.

Shoppers in Colorado’s medical channel spend on average $20.46 for concentrates cartridges. Meanwhile, consumers in Oregon’s medical channel fork over the most for cartridges, with an average price of $40.16.

How about the land of brownies, caramels and teas? Edibles in Colorado’s medical channel average $12.42. But those who frequent Oregon’s recreational marketplace spend quite a bit more for their edibles — $18.27.

The news is not all rosy for Coloradans, however. While the medical channel is a comparative bargain, prices within the much busier recreational marketplace are quite a bit higher, and often more expensive than in other states.

Looking for edibles? They will set you back $17.17 in Colorado’s recreational market. But in Oregon’s medical channel they sell for $16.20, in California the average retail price is $13.77 and Washingtonians spend quite a bit less — $12.96. Flower, too, is cheaper in Washington’s single recreational marketplace than in Colorado’s recreational channel — $5.74 in Washington compared to $6.27 in Colorado.

Doug Brown

Doug Brown

Douglas Brown spent more than two decades in newspaper and magazine newsrooms around the country, covering everything from the White House and Capitol Hill to technology policy to crime in New Mexico. Now, he runs Contact High Communications, a leading cannabis public relations firm based in Boulder, CO. He can be reached at www.contacthighco.com

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Advocates for recreational marijuana in Delaware ‘optimistic’ this is the year

Delaware lawmakers who support legalizing recreational marijuana are taking a run at it for the sixth straight year, and the lead sponsor says he’s “feeling optimistic.” First introduced in 2017, a bill to legalize weed fell four votes short of passage in the Delaware House of Representatives in 2018 but since then has not reached…

Guns or marijuana, but not both

While marijuana became legal for adults to purchase in Montana on New Year’s Day, a key federal agency has confirmed a fact underreported in coverage of the state’s new marijuana program: It remains illegal under federal law for individuals to simultaneously possess marijuana or marijuana products and firearms, and penalties for violating that law are…

As Oklahoma’s medical marijuana industry booms, regulators struggle to keep up

Row by row, Oklahoma Bureau of Narcotics and Dangerous Drugs agents and Garvin County deputies cut down 2,500 marijuana plants and loaded them in a dump truck for destruction during an April 2021 raid near Pauls Valley. The grow operation had a Oklahoma Medical Marijuana Authority license, but had not obtained an additional permit from…

European Cannabis Round-Up; GW Pharma’s Cannabis Pipeline, Irish CBD In Court, UK Medical Cannabis Price Row, Italian Referendum, Poland And Malta

GW Pharmaceuticals has released further details of its cannabis development pipeline. With Epidiolex approved in the US last year it is also expecting approval for Sativex where two phase 3 trials are ongoing. Work is also underway on the use of Sativex in spinal cord injury, post-traumatic stress disorder and other forms of spasticity. Further…

More Categories

Back To Top
×Close search
Search